LD-2 disclosure · 1st Quarter - Report
OS THERAPIES
Coverage · No income or expenses were reported on this filing.
Client
- Name
- OS THERAPIES
- Description
- biotechnology company
- Location
- New York · United States of America
Registrant
- Description
- public policy consulting
- Location
- Arlington, Virginia, United States of America
Lobbying activities
2 issuesPharmacy
cancer immunotherapy and antibody treatment; osteosarcoma
LobbyistsJENNIFER BELL · SHAWN FRIESEN · JENNIFER HOLLAND
Covered position (JENNIFER BELL): Health Policy Advisor, Sen. Finance Committee; Legislative Assistant, Rep. John Thune (R-SD)
Covered position (SHAWN FRIESEN): Legislative Director, Rep. Mac Collins (R-GA)); Legislative Assistant, Rep. Tom Ewing (IL-15); Clerk, House Judiciary Committee
Covered position (JENNIFER HOLLAND): Scheduler, Rep. Mary Kaptur (OH-09); Operations Director, Rep. Donald Norcross (NJ-01); Scheduler, Rep. Debbie Dingell (MI-06)
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA)
Health Issues
cancer immunotherapy and antibody treatment; osteosarcoma
LobbyistsJENNIFER BELL · JENNIFER HOLLAND
Covered position (JENNIFER BELL): Health Policy Advisor, Sen. Finance Committee; Legislative Assistant, Rep. John Thune (R-SD)
Covered position (JENNIFER HOLLAND): Scheduler, Rep. Mary Kaptur (OH-09); Operations Director, Rep. Donald Norcross (NJ-01); Scheduler, Rep. Debbie Dingell (MI-06)
SENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA)